Citigroup Global Markets India Pvt. Ltd. (Manager to the Offer) has submitted to the Exchange a copy of Disclosure in relation to number of Equity Shares tendered in connection with the Open Offer on May 05,2025

Open offerAcquisition announcedStrategic Transactions View source PDF Explain this filing

SANOFICONR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.1%Reaction day

₹4948.89

prior close

₹4954.20

announcement price

In-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)-2.6%+2.7% vs market

Pharmaceuticals peers, median of 147sector-2.4%+2.5% vs sector

On the reaction day the stock moved 2.7 pts more than Nifty Microcap 250 and 2.5 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

-0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.1-2.6+2.7-2.4+2.5

Next day

+0.1-1.4+1.5-1.8+1.9

+0.2-2.2+2.4-3.1+3.3

-1.1-2.3+1.2-3.6+2.5

-1.0+2.2-3.2-0.3-0.6

-0.4+3.9-4.2+0.9-1.3

+1.4+6.6-5.2+2.6-1.2

15d

+3.0+9.5-6.5+4.8-1.8

+1.3+11.4-10.1+3.6-2.3

+7.2+13.8-6.6+5.8+1.3

+7.3+9.9-2.6+2.2+5.1

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 147Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Citigroup Global Markets, the manager to the open offer for Sanofi Consumer Healthcare India, has disclosed that 15,29,681 equity shares (25.55% of the offer size) have been tendered by public shareholders as of May 5, 2025. The tendering broke down as 13,03,988 shares on May 3 and 46,758 shares on May 5. The open offer is for up to 59,87,962 shares (26% of voting capital) by Opal Bidco SAS along with Clayton, Dubilier & Rice Fund XII as persons acting in concert. Tendered shares will still be subject to validation, and the final accepted number may differ from the tendered count.

Likely market impact

Public shareholders have tendered nearly the full 26% offer size, indicating strong acceptance of the open offer. Once validated, this acquisition will result in a change in control of Sanofi Consumer Healthcare India, potentially affecting liquidity and shareholder composition post-offer.